Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

Mylan

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mylan's 2012 sales performance.

First Herceptin biosimilar cleared in Europe

First Herceptin biosimilar cleared in Europe

favour of approval for Biocon and Mylan’s version of the drug in September. ... Biocon and Mylan withdrew the filing for their biosimilar in the EU, after questions were raised about manufacturing quality compliance issues, but said recently these have

Change in the pharma industry is inevitable

Change in the pharma industry is inevitable And this survey was conducted before Mylan’s scandalous EpiPen price-hike. Change across the entire pharmaceutical industry is inevitable.

Court throws out Allergan's patent deal with Native American tribe

Court throws out Allergan's patent deal with Native American tribe patients.”. Meanwhile, the decision means that generic competitors Mylan and Teva could soon be free to market a more cost-effective version of the eye drop.

Building a bright future

Building a bright future Building a bright future. Mylan takes a bold approach as it doubles its pipeline through R&D and acquisitions. ... 2011, which features a dedication from then company president Heather Bresch, stating: “Mylan is drawn to the unfamiliar, the bold and

Teva faces early rival to longer-acting Copaxone in US

Teva faces early rival to longer-acting Copaxone in US Teva faces early rival to longer-acting Copaxone in US. US regulator approves Mylan’s MS drug. ... The approval and launch is also big news for Indian company Natco Pharma, which partnered with Mylan on developing the generic and will share profits on

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Shining a light on the true cost of patient care
Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore how the proposed national patient data sharing scheme would change the NHS...
city
The real-world data conundrum
How data is changing the healthcare industries...
Where is health behaviour change heading?
Cures rely on patient adherence to succeed, and health behaviour change in any non-compliant patient is essential, this post explores where health behaviour change is heading....

Infographics